On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.99 USD | +1.23% | +0.11% | -18.51% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.51% | 84.08B | |
+46.68% | 765B | |
-6.14% | 354B | |
+20.17% | 331B | |
+8.84% | 299B | |
+18.94% | 248B | |
-1.72% | 219B | |
+10.99% | 216B | |
+5.37% | 164B | |
-2.74% | 162B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company